Clinical Trial Update: Prospective Clinical Study on the Clinical Efficacy and Prognostic Outcome of ICS/LABA Combined With Liqin Zhike Formula in the Treatment of Cough Variant Asthma [NA]

View source ↗

Summary

A prospective clinical study is evaluating the efficacy and prognostic outcomes of combining an inhaled corticosteroid/long-acting beta-agonist (ICS/LABA) with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Cough-variant Asthma

Drugs mentioned

• ICS/LABA combination therapy (Inhaled corticosteroid / long-acting beta-agonist)
• Liqin Zhike Formula

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Asthma | NA | Status: NOT_YET_RECRUITING